Pharmacokinetics, Pharmacodynamics, and Proposed Dosing of the Oral JAK1 and JAK2 Inhibitor Baricitinib in Pediatric and Young Adult CANDLE and SAVI Patients.
Clin Pharmacol Ther
; 104(2): 364-373, 2018 08.
Article
in En
| MEDLINE
| ID: mdl-29134648
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autoimmune Diseases
/
Sulfonamides
/
Azetidines
/
Janus Kinase 1
/
Janus Kinase 2
/
Drug Dosage Calculations
/
Janus Kinase Inhibitors
/
Inflammation
/
Models, Biological
Type of study:
Diagnostic_studies
/
Prognostic_studies
Limits:
Adolescent
/
Adult
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Clin Pharmacol Ther
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: